KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Common Equity (2017 - 2025)

Elanco Animal Health's Common Equity history spans 9 years, with the latest figure at $6.7 billion for Q3 2025.

  • For Q3 2025, Common Equity rose 3.46% year-over-year to $6.7 billion; the TTM value through Sep 2025 reached $6.7 billion, up 3.46%, while the annual FY2024 figure was $6.1 billion, 2.04% down from the prior year.
  • Common Equity for Q3 2025 was $6.7 billion at Elanco Animal Health, roughly flat from $6.8 billion in the prior quarter.
  • Across five years, Common Equity topped out at $8.0 billion in Q1 2021 and bottomed at $5.9 billion in Q2 2024.
  • The 5-year median for Common Equity is $6.8 billion (2025), against an average of $6.9 billion.
  • The largest annual shift saw Common Equity grew 20.21% in 2021 before it decreased 19.92% in 2024.
  • A 5-year view of Common Equity shows it stood at $7.5 billion in 2021, then dropped by 2.92% to $7.3 billion in 2022, then decreased by 14.62% to $6.2 billion in 2023, then decreased by 2.04% to $6.1 billion in 2024, then increased by 10.71% to $6.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Common Equity are $6.7 billion (Q3 2025), $6.8 billion (Q2 2025), and $6.4 billion (Q1 2025).